Rheumatoid Arthritis: Current Treatments and New Therapies

Maria Benito

IPN Communications, Dublin, Ireland

Dr. Maria Benito, IPN Communications, Dublin, Ireland.

Keywords: Rheumatoid Arthritis; NSAIDs; DMARDs; JAKs; New Therapies

Abstract

Rheumatoid arthritis (RA) is a chronic inflammatory disease that affects 1% of the general population. It is characterised by a dysregulation of the immune system that induces persistent synovitis and systemic inflammation, and can lead to joint destruction [1]. Despite a common clinical presentation, RA displays multiple pathogenic pathways.
The main aim of treatments in RA is to control inflammation and relieve symptoms, therefore preventing the joint damage. The current trend in practise is to treat the inflammation early so the disease can be controlled and facilitate remission [2]. This is in theory; in the practice however, not all RA patients respond adequately to treatments. Today, classic and novel treatments cooperate with targeted therapies and precision medicine to treat RA [3,4].

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).